BioCentury
ARTICLE | Financial News

Third Rock names new venture partners

May 15, 2013 12:39 AM UTC

Healthcare VC firm Third Rock Ventures named John Maraganore, CEO of RNAi company Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY), a venture partner. Third Rock also named Daniel Lynch and Steven Paul as venture partners. Lynch joined Third Rock in 2011, while Paul joined the firm in 2010. Additionally, Third Rock named James Geraghty, formerly SVP of North American strategy and business development at Sanofi (Euronext:SAN; NYSE:SNY), an entrepreneur-in-residence. ...